Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05296941 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)

Study acronym: PMOD
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v3
  2. Start date: Jan 1, 2023 to Aug 1, 2023v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cancer is a complex disease; its different causes and types have a strong impact on patient treatment and prognosis. To improve understanding of the disease, its causes and progression, the investigators will develop a simple, cost-effective system for continuous control of mucosal lesions with non-invasive brush biopsy that can be managed in primary dental care, as an alternative to tissue biopsy in order to reduce the number of oral cavity cancers.
Trial Details
NCT Number NCT05296941
Lead Sponsor Dalarna County Council, Sweden
Collaborators: Uppsala University
Conditions
(from sponsor)		 Mouth Neoplasms
Related terms Erythroplasia, Leukoplakia, Lichen Planus, Oral, Mouth Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov